These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1153 related articles for article (PubMed ID: 8462144)

  • 1. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized evaluation of a nonthoracotomy implantable cardioverter defibrillator lead system. Endotak/PRX Investigator Group.
    Baker JH; Epstein AE; Voshage-Stahl L
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):72-8. PubMed ID: 9121974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation. Implications for use of implantable defibrillator.
    Raitt MH; Dolack GL; Kudenchuk PJ; Poole JE; Bardy GH
    Circulation; 1995 Apr; 91(7):1996-2001. PubMed ID: 7895358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results and experiences of transvenous endocardial defibrillator therapy].
    Trappe HJ; Fieguth HG; Weber-Conrad O; Schöhl W; Wahlers T; Kielblock B; Wenzlaff P; Klein H; Lichtlen PR
    Med Klin (Munich); 1992 Dec; 87(12):615-21. PubMed ID: 1287422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator. Nonthoracotomy approach to implantation.
    Yee R; Klein GJ; Leitch JW; Guiraudon GM; Guiraudon CM; Jones DL; Norris C
    Circulation; 1992 Jan; 85(1):196-204. PubMed ID: 1728450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complications in transvenous and transvenous-subcutaneous implantable defibrillator systems].
    Podczeck A; Hief C; Veit F; Jakl G; Kaltenbrunner W; Nürnberg M; Frohner K; Steinbach K
    Z Kardiol; 1994 May; 83(5):366-72. PubMed ID: 8053246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of successful nonthoracotomy cardioverter-defibrillator implantation: experience in 101 patients using two different lead systems.
    Brooks R; Garan H; Torchiana D; Vlahakes GJ; Jackson G; Newell J; McGovern BA; Ruskin JN
    J Am Coll Cardiol; 1993 Dec; 22(7):1835-42. PubMed ID: 8245336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode.
    Bardy GH; Dolack GL; Kudenchuk PJ; Poole JE; Mehra R; Johnson G
    Circulation; 1994 Mar; 89(3):1090-3. PubMed ID: 8124794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience with a new transvenous defibrillation system.
    Trappe HJ; Klein H; Fieguth HG; Kielblock B; Wenzlaff P; Lichtlen PR
    Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 2):134-40. PubMed ID: 7681560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of delivered therapy for VT or VF in patients with third-generation implantable cardioverter defibrillators.
    Rabinovich R; Muratore C; Iglesias R; Gonzalez M; Serafrica M; Sosa Liprandi A
    Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 2):133-6. PubMed ID: 7724386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations and late complications of third-generation automatic cardioverter-defibrillators.
    Nunain SO; Roelke M; Trouton T; Osswald S; Kim YH; Sosa-Suarez G; Brooks DR; McGovern B; Guy M; Torchiana DF
    Circulation; 1995 Apr; 91(8):2204-13. PubMed ID: 7697850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
    J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia].
    Adragão P; Parreira L; Neves J; Morgado F; Abecassis M; Almeida M; Martins D; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1996 Mar; 15(3):195-206, 179, 181. PubMed ID: 8634168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transvenous biventricular defibrillation.
    Meisel E; Butter C; Philippon F; Higgins S; Strickberger SA; Smith J; Hahn S; Michel U; Schubert B; Pfeiffer D
    Am J Cardiol; 2000 Nov; 86(9A):76K-85K. PubMed ID: 11084104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Implantation of defibrillators with transvenous-subcutaneous electrode systems].
    Hief C; Podczeck A; Veit F; Frohner K; Kaltenbrunner W; Nürnberg M; Steinbach K
    Wien Klin Wochenschr; 1993; 105(1):12-6. PubMed ID: 8438594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.